Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CNS

Cohen & Steers Reports 12% Revenue Growth in Q4

Cohen & Steers, Inc. (NYSE: CNS) has reported its financial results for the fourth quarter and year ended December 31, 2025. Here are the key highlights from the report:

  • Total revenue for the fourth quarter of 2025 was $267.5 million, an increase of 12% from the same period in 2024.
  • Net income attributable to Cohen & Steers, Inc. was $94.8 million for the fourth quarter of 2025, compared to $81.6 million for the same period in 2024.
  • For the full year 2025, total revenue reached $1.02 billion, up 10% from the previous year.
  • Net income attributable to Cohen & Steers, Inc. for the full year 2025 amounted to $321.4 million, compared to $280.5 million in 2024.
  • Assets under management (AUM) as of December 31, 2025, were $112.4 billion, a 14% increase from the end of 2024.

It's worth noting that Cohen & Steers will be hosting a conference call to discuss these results on January 23, 2026, where the company's leadership team will provide further insights into the performance and outlook.

Cohen & Steers, founded in 1986, is a global investment manager specializing in real assets and alternative income, with headquarters in New York City and offices in several major financial centers around the world. Following these announcements, the company's shares moved 1.14%, and are now trading at a price of $70.42. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS